Is GBLP or RYLD a better dividend investment in 2026?

GBLP currently yields 4000.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: GBLP offers higher current income.

What is the dividend yield difference between GBLP and RYLD?

GBLP has a forward dividend yield of 4000.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 3987.86 percentage points.

Home › Compare › GBLP vs RYLD

GBLP vs RYLD: Dividend Comparison 2026

GBLP yields 4000.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBLP wins by $7175340620755.83M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GBLP

● Live price

4000.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7175340620755.87M

Annual income

$6,839,006,593,197,835,000.00

Full GBLP calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — GBLP vs RYLD

📍 GBLP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GBLP	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GBLP + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GBLP pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBLP

Annual income on $10K today (after 15% tax)

$340,000.00/yr

After 10yr DRIP, annual income (after tax)

$5,813,155,604,218,160,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, GBLP beats the other by $5,813,155,604,218,158,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBLP + RYLD for your $10,000?

GBLP: 50%RYLD: 50%

100% RYLD50/50100% GBLP

Portfolio after 10yr

$3587670310377.96M

Annual income

$3,419,503,296,598,919,000.00/yr

Blended yield

95.31%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBLP buys

RYLD buys

No recent congressional trades found for GBLP or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGBLPRYLD

Forward yield	4000.00% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7175340620755.87M ✓	$44.5K
Annual income after 10y	$6,839,006,593,197,835,000.00 ✓	$2,587.35
Total dividends collected	$7152397773804.84M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: GBLP vs RYLD ($10,000, DRIP)

Year	GBLP Portfolio	GBLP Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$410,700	$400,000.00	$11,914	$1,213.65	+$398.8K → GBLP
2	$15,792,720	$15,353,271.03	$14,099	$1,351.30	+$15.78M → GBLP
3	$568,657,142	$551,758,931.89	$16,580	$1,494.55	+$568.64M → GBLP
4	$19,176,207,860	$18,567,744,718.20	$19,384	$1,642.61	+$19176.19M → GBLP
5	$605,696,028,890	$585,177,486,479.73	$22,535	$1,794.70	+$605696.01M → GBLP
6	$17,922,210,653,594	$17,274,115,902,681.27	$26,063	$1,950.00	+$17922210.63M → GBLP
7	$496,869,793,504,300	$477,693,028,104,954.00	$29,995	$2,107.69	+$496869793.47M → GBLP
8	$12,908,672,105,251,704	$12,377,021,426,202,104.00	$34,361	$2,266.99	+$12908672105.22M → GBLP
9	$314,330,866,876,668,540	$300,518,587,724,049,200.00	$39,194	$2,427.12	+$314330866876.63M → GBLP
10	$7,175,340,620,755,871,000	$6,839,006,593,197,835,000.00	$44,525	$2,587.35	+$7175340620755.83M → GBLP

GBLP vs RYLD: Complete Analysis 2026

GBLP — Stock

Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.

Full GBLP Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this GBLP vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBLP vs SCHD GBLP vs JEPI GBLP vs O GBLP vs KO GBLP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.